Foster City, CA
22nd February 2018
Marching at the Double-quick to Successful Submissions with Innovative Automation within the Study Life Cycle
The first US SDE of 2018 was hosted by PointCross on February 22nd. This event was held in the Wind Room at the Foster City Community Center in Foster City, California. The theme of this event focused on innovation and automation within the study life cycle, which attracted many attendees from various Biopharmaceutical and CRO companies in the San Francisco Bay Area. Speakers covered topics and areas such as: automation and machine learning with non-clinical SEND submissions; how to ensure your submission supports the automated review process at the FDA and PMDA; putting data standards to work to fuel innovation; creation of define XML from metadata and meta programming; using SPARQL queries to automatically generate define.xml from clinical trial data as RDF; multi-modal signal detection for drug safety and surveillance; and finally, building quality and efficiency into biometrics tools and processes. This excellent event was successful because of the contributions from our sponsors, co-chairs, speakers, PHUSE Office and organizing committee. Thanks to all who volunteered and attended this event.
Accelerating Consistent and Quality Nonclinical SEND Study Submissions with Automation and Machine Learning – Suresh Madhavan & Kurien Abraham, PointCross
Raising the Bar for Data Standardization: How to Ensure Your Submission Supports the Automated Review Process at FDA and PMDA? – Sergiy Sirichenko, Pinnancle 21
Have Data Standards – Now What? Next Steps Required to Put Them to Work to Fuel the Furnace of Data Innovation – Gregory Steffens, Noumena Solutions
Selecting a Method for Creation of First Define-XML – Paul Hamilton & Sunil Pursarla, Omeros
Automatically Generate Define-XML from Clinical Trials Data as RDF with SPARQL Query – Ippei Akiya, DataDriven
Multimodal Drug Safety – Rave Harpaz, Oracle
Building Quality and Efficiency into Biometrics Tools and Processes – Linda Collins & David Brega, PharmaStat
View the event brochure.